Normal renal function (N = 921) | CKD/ESRD (N = 95) | Odds ratio (95% CI) | P-value | ||
---|---|---|---|---|---|
Any strategy change | 224/921 (24.3) | 32/95 (33.7) | 1.58 (1.01–2.48) | 0.047 | |
HFUS/TTFM | 172/921 (18.7) | 25/95 (26.3) | 1.56 (0.96–2.53) | 0.075 | |
Visual/tactile feedback | 34/921 (3.7) | 10/95 (10.5) | 3.08 (1.47–6.43) | 0.003 | |
Unclassified change | 35/921 (3.8) | 3/95 (3.2) | 0.83 (0.25–2.74) | 0.75 | |
Changes related to the aorta | |||||
Any surgical change | 69/921 (7.5) | 11/95 (11.6) | 1.62 (0.74–3.23) | 0.16 | |
HFUS | 64/921 (6.9) | 10/95 (10.5) | |||
Visual/tactile feedback | 3/921 (0.3) | 1/95 (1.1) | |||
Unclassified change | 2/921 (0.2) | 0/95 (0.0) | |||
Changes related to in situ conduits | |||||
Any surgical change | 14/921 (1.5) | 4/95 (4.2) | 2.84 (0.67–9.30) | 0.079 | |
HFUS and/or TTFM | 9/921 (1.0) | 1/95 (1.1) | |||
Visual/tactile feedback | 3/921 (0.3) | 3/95 (3.2) | |||
Unclassified change | 2/921 (0.2) | 0/95 (0.0) | |||
Changes related to coronary targets | |||||
Any surgical change | 98/921 (10.6) | 11/95 (11.6) | 1.10 (0.51–2.16) | 0.73 | |
HFUS | 66/921 (7.2) | 7/95 (7.4) | |||
Visual/tactile feedback | 10/921 (1.1) | 1/95 (1.1) | |||
Unclassified change | 24/921 (2.6) | 3/95 (3.2) | |||
Changes related to grafts (per patient) | |||||
Any surgical change | 68/921 (7.4) | 11/95 (11.6) | 1.64 (0.75–3.28) | 0.16 | |
HFUS and/or TTFM | 44/921 (4.8) | 7/95 (7.4) | |||
Visual/tactile feedback | 20/921 (2.2) | 7/95 (7.4) | |||
Unclassified change | 6/921 (0.7) | 0/95 (0.0) | |||
Changes related to grafts (per graft) | |||||
Any surgical change | 83/2433 (3.4) | 17/242 (7.0) | 2.14 (1.17–3.71) | 0.008 | |
HFUS and/or TTFM | 53/2433 (2.2) | 9/242 (3.7) | |||
Visual/tactile feedback | 23/2433 (0.9) | 8/242 (3.3) | |||
Unclassified change | 7/2433 (0.3) | 0/242 (0.0) |